Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Krontiras

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancerAshka Y Pandya, Lynya I Talley, Andra R Frost, et al.
Annals of Surgical Oncology|March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trialsAnne M Wallace, Linda K Han, Stephen P Povoski, et al.
Annals of Surgical Oncology|November 24, 2017
Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient EncountersJeffrey Landercasper, Oluwadamilola M Fayanju, Lisa Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2008
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancersMarta Guix, Nara de Matos Granja, Ingrid Meszoely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013Tari A King, Jaclyn P Lyman, Mithat Gonen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2006
Breast cancer screening and diagnosisTherese B Bevers, Benjamin O Anderson, Ermelinda Bonaccio, et al.
Clinical Breast Cancer|August 14, 2010
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancerAndres Forero-Torres, Mansoor N Saleh, Janice A Galleshaw, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2007
Breast cancer risk reductionTherese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast CancerAndres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Breast cancer risk reductionTherese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancerAshka Y Pandya, Lynya I Talley, Andra R Frost, et al.
Annals of Surgical Oncology|March 19, 2013
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trialsAnne M Wallace, Linda K Han, Stephen P Povoski, et al.
Annals of Surgical Oncology|November 24, 2017
Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient EncountersJeffrey Landercasper, Oluwadamilola M Fayanju, Lisa Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2008
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancersMarta Guix, Nara de Matos Granja, Ingrid Meszoely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013Tari A King, Jaclyn P Lyman, Mithat Gonen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2006
Breast cancer screening and diagnosisTherese B Bevers, Benjamin O Anderson, Ermelinda Bonaccio, et al.
Clinical Breast Cancer|August 14, 2010
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancerAndres Forero-Torres, Mansoor N Saleh, Janice A Galleshaw, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2007
Breast cancer risk reductionTherese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast CancerAndres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 26, 2010
Breast cancer risk reductionTherese B Bevers, Deborah K Armstrong, Banu Arun, et al.
Pageof 6